{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T09:06:20Z","timestamp":1768640780660,"version":"3.49.0"},"reference-count":164,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.biopha.2024.116787","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T05:03:06Z","timestamp":1716440586000},"page":"116787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A peripheral system disease\u2014Pulmonary hypertension"],"prefix":"10.1016","volume":"175","author":[{"given":"Yang","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junpeng","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangcheng","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1647-2825","authenticated-orcid":false,"given":"Qidi","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shasha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116787_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1750-1172-8-97","article-title":"Pulmonary arterial hypertension","volume":"8","author":"Montani","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.biopha.2024.116787_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11906-014-0469-1","article-title":"Neuroinflammation in pulmonary hypertension: concept, facts, and relevance","volume":"16","author":"Hilzendeger","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"issue":"12","key":"10.1016\/j.biopha.2024.116787_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101368","article-title":"Pulmonary hypertension or pulmonary arterial hypertension in idiopathic pleuroparenchymal fibroelastosis: an updated comprehensive review","volume":"47","author":"Cueto-Robledo","year":"2022","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.biopha.2024.116787_bib4","article-title":"Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116787_bib5","doi-asserted-by":"crossref","first-page":"L249","DOI":"10.1152\/ajplung.00258.2015","article-title":"Endothelial HIF signaling regulates pulmonary fibrosis-associated pulmonary hypertension","volume":"310","author":"Bryant","year":"2016","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2024.116787_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102348","article-title":"Novel and robust treatment of pulmonary hypertension with netrin-1 and netrin-1-derived small peptides","volume":"55","author":"Murugesan","year":"2022","journal-title":"Redox Biol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116787_bib7","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.3390\/molecules27123724","article-title":"Oxidative stress and antioxidative therapy in pulmonary arterial hypertension","volume":"27","author":"Xu","year":"2022","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.biopha.2024.116787_bib8","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s40520-018-1063-1","article-title":"Autophagy and its role in pulmonary hypertension","volume":"31","author":"Chen","year":"2019","journal-title":"Aging Clin. Exp. Res"},{"issue":"1","key":"10.1016\/j.biopha.2024.116787_bib9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/HYPERTENSIONAHA.122.19397","article-title":"The Novel Lysosomal Autophagy Inhibitor (ROC-325) Ameliorates Experimental Pulmonary Hypertension","volume":"80","author":"Bao","year":"2023","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.biopha.2024.116787_bib10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s11239-020-02356-5","article-title":"The role of \u03b2-catenin in pulmonary artery endothelial-mesenchymal transformation in rats with chronic thromboembolic pulmonary hypertension","volume":"52","author":"Zeng","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"issue":"14","key":"10.1016\/j.biopha.2024.116787_bib11","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review","volume":"327","author":"Ruopp","year":"2022","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.biopha.2024.116787_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101466","article-title":"Selexipag in Patients With Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"48","author":"Qin","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"issue":"134","key":"10.1016\/j.biopha.2024.116787_bib13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1183\/09059180.00007414","article-title":"The right ventricle in pulmonary arterial hypertension","volume":"23","author":"Naeije","year":"2014","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.biopha.2024.116787_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1164\/rccm.201201-0058PP","article-title":"Estrogen paradox in pulmonary hypertension: current controversies and future perspectives","volume":"186","author":"Umar","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.biopha.2024.116787_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/CIRCRESAHA.115.303404","article-title":"The genetics of pulmonary arterial hypertension","volume":"115","author":"Austin","year":"2014","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2024.116787_bib16","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3389\/fphys.2019.01186","article-title":"Experimental Pulmonary Hypertension Is Associated With Neuroinflammation in the Spinal Cord","volume":"10","author":"Vaillancourt","year":"2019","journal-title":"Front Physiol."},{"issue":"20","key":"10.1016\/j.biopha.2024.116787_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/nu14204278","article-title":"The Role and Mechanism of Gut Microbiota in Pulmonary Arterial Hypertension","volume":"14","author":"Chen","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2024.116787_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fcvm.2018.00110","article-title":"Metabolic Reprogramming in the Heart and Lung in a Murine Model of Pulmonary Arterial Hypertension","volume":"5","author":"Izquierdo-Garcia","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.biopha.2024.116787_bib19","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03406-2020","article-title":"Epigenetics and pulmonary diseases in the horizon of precision medicine: a review","volume":"57","author":"Benincasa","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2024.116787_bib20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cpcardiol.2011.08.002","article-title":"Pulmonary arterial hypertension","volume":"36","author":"McLaughlin","year":"2011","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.biopha.2024.116787_bib21","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.mayocp.2020.04.039","article-title":"Pulmonary Hypertension: A Brief Guide for Clinicians","volume":"95","author":"Mandras","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.biopha.2024.116787_bib22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/13880209.2020.1831026","article-title":"Preventive treatment with ginsenoside Rb1 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats and involves store-operated calcium entry inhibition","volume":"58","author":"Wang","year":"2020","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2024.116787_bib23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/jcmm.15671","article-title":"Astragaloside IV attenuates inflammatory response mediated by NLRP-3\/calpain-1 is involved in the development of pulmonary hypertension","volume":"25","author":"Sun","year":"2021","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.biopha.2024.116787_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2024.116787_bib25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00441-016-2539-y","article-title":"Pulmonary vascular remodeling in pulmonary hypertension","volume":"367","author":"Tuder","year":"2017","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.biopha.2024.116787_bib26","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41467-019-11500-6","article-title":"CD146-HIF-1\u03b1 hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension","volume":"10","author":"Luo","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116787_bib27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1164\/rccm.201812-2290OC","article-title":"PFKFB3 in Smooth Muscle Promotes Vascular Remodeling in Pulmonary Arterial Hypertension","volume":"200","author":"Kovacs","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.biopha.2024.116787_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12931-020-1331-4","article-title":"Mesenchymal stromal cell-derived exosomes improve pulmonary hypertension through inhibition of pulmonary vascular remodeling","volume":"21","author":"Zhang","year":"2020","journal-title":"Respir. Res"},{"key":"10.1016\/j.biopha.2024.116787_bib29","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.4049\/jimmunol.1900239","article-title":"Nonclassical monocytes sense hypoxia, regulate pulmonary vascular remodeling, and promote pulmonary hypertension","volume":"204","author":"Yu","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2024.116787_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106238","article-title":"Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective","volume":"180","author":"Wang","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2024.116787_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.113.301141","article-title":"Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension","volume":"115","author":"Rabinovitch","year":"2014","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2024.116787_bib32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","article-title":"Mechanisms of disease: pulmonary arterial hypertension","volume":"8","author":"Schermuly","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116787_bib33","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1164\/rccm.202110-2274OC","article-title":"Macrophage-NLRP3 activation promotes right ventricle failure in pulmonary arterial hypertension","volume":"206","author":"Al-Qazazi","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.biopha.2024.116787_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/HJH.0b013e328332bcdb","article-title":"Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension","volume":"28","author":"Crosswhite","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.biopha.2024.116787_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111081","article-title":"Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats","volume":"133","author":"Tang","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.116787_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1465-9921-15-47","article-title":"Inflammatory cytokines in pulmonary hypertension","volume":"15","author":"Groth","year":"2014","journal-title":"Respir. Res"},{"key":"10.1016\/j.biopha.2024.116787_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1162556","article-title":"Inflammation and immunity in the pathogenesis of hypoxic pulmonary hypertension","volume":"14","author":"Ye","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.116787_bib38","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pcad.2012.07.006","article-title":"Immune and inflammatory mechanisms in pulmonary arterial hypertension","volume":"55","author":"El Chami","year":"2012","journal-title":"Prog. Cardiovasc Dis."},{"key":"10.1016\/j.biopha.2024.116787_bib39","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1089\/ars.2019.7753","article-title":"Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension","volume":"31","author":"Fulton","year":"2019","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2024.116787_bib40","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.116787_bib41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","article-title":"Targeting fibrosis, mechanisms and cilinical trials","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2024.116787_bib42","doi-asserted-by":"crossref","first-page":"j5492","DOI":"10.1136\/bmj.j5492","article-title":"Pulmonary arterial hypertension: pathogenesis and clinical management","volume":"360","author":"Thenappan","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.biopha.2024.116787_bib43","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3389\/fphys.2019.01233","article-title":"Oxidative Stress and Its Implications in the Right Ventricular Remodeling Secondary to Pulmonary Hypertension","volume":"10","author":"Mikhael","year":"2019","journal-title":"Front Physiol."},{"key":"10.1016\/j.biopha.2024.116787_bib44","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.semcdb.2012.04.003","article-title":"Oxidative stress and adult neurogenesis--effects of radiation and superoxide dismutase deficiency.","volume":"23","author":"Huang","year":"2012","journal-title":"Semin Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2024.116787_bib45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.freeradbiomed.2023.02.020","article-title":"Plasmonic optical fiber biosensor development for point-of-care detection of malondialdehyde as a biomarker of oxidative stress","volume":"199","author":"Bencivenga","year":"2023","journal-title":"Free Radic. Biol. Med"},{"issue":"2","key":"10.1016\/j.biopha.2024.116787_bib46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1752-8062.2008.00035.x","article-title":"Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension","volume":"1","author":"Masri","year":"2008","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.biopha.2024.116787_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3795320","article-title":"Prognostic Value of Oxidative Stress Markers in Patients with Pulmonary Arterial or Chronic Thromboembolic Pulmonary Hypertension","volume":"2019","author":"Smukowska-Gorynia","year":"2019","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.biopha.2024.116787_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4353462","article-title":"Pentaerythritol Tetranitrate In Vivo Treatment Improves Oxidative Stress and Vascular Dysfunction by Suppression of Endothelin-1 Signaling in Monocrotaline-Induced Pulmonary Hypertension","volume":"2017","author":"Steven","year":"2017","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.biopha.2024.116787_bib49","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12890-015-0045-8","article-title":"Oxidative stress and nitric oxide signaling related biomarkers in patients with pulmonary hypertension: a case control study","volume":"15","author":"Zhang","year":"2015","journal-title":"BMC Pulm. Med"},{"issue":"3","key":"10.1016\/j.biopha.2024.116787_bib50","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/cphy.c120024","article-title":"Reactive oxygen species in pulmonary vascular remodeling","volume":"3","author":"Aggarwal","year":"2013","journal-title":"Compr. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116787_bib51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/15548627.2017.1389823","article-title":"Autophagy and inflammation in chronic respiratory disease","volume":"14","author":"Racanelli","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2024.116787_bib52","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.2147\/DDDT.S213817","article-title":"eIF2\u03b1 promotes vascular remodeling via autophagy in monocrotaline-induced pulmonary arterial hypertension rats","volume":"13","author":"Guo","year":"2019","journal-title":"Drug Des. Devel Ther."},{"issue":"3","key":"10.1016\/j.biopha.2024.116787_bib53","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/jcmm.12208","article-title":"Apelin inhibits the proliferation and migration of rat PASMCs via the activation of PI3K\/Akt\/mTOR signal and the inhibition of autophagy under hypoxia","volume":"18","author":"Zhang","year":"2014","journal-title":"J. Cell Mol. Med"},{"issue":"14","key":"10.1016\/j.biopha.2024.116787_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20143435","article-title":"Glucagon-Like Peptide-1 Receptor Agonist Attenuates Autophagy to Ameliorate Pulmonary Arterial Hypertension through Drp1\/NOX- and Atg-5\/Atg-7\/Beclin-1\/LC3\u03b2 Pathways","volume":"20","author":"Wu","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116787_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101679","article-title":"Complex interplay between autophagy and oxidative stress in the development of pulmonary disease","volume":"36","author":"Ornatowski","year":"2020","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116787_bib56","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/path.5322","article-title":"Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension","volume":"249","author":"Gomez-Puerto","year":"2019","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116787_bib57","doi-asserted-by":"crossref","first-page":"731","DOI":"10.14336\/AD.2018.1001","article-title":"Galectin-3 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension","volume":"10","author":"Li","year":"2019","journal-title":"Aging Dis."},{"issue":"18","key":"10.1016\/j.biopha.2024.116787_bib58","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.115.020617","article-title":"In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug","volume":"133","author":"Hopper","year":"2016","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.biopha.2024.116787_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050761","article-title":"Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension","volume":"17","author":"Leopold","year":"2016","journal-title":"Int J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.biopha.2024.116787_bib60","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/CIRCULATIONAHA.116.022479","article-title":"Endothelial-to-Mesenchymal Transition: An Evolving Paradigm and a Promising Therapeutic Target in PAH","volume":"133","author":"Stenmark","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.biopha.2024.116787_bib61","first-page":"L256","article-title":"Endothelial HIF-2\u03b1 contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition","volume":"314","author":"Tang","year":"2018","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2024.116787_bib62","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fimmu.2018.00294","article-title":"Endothelial to Mesenchymal Transition Represents a Key Link in the Interaction between Inflammation and Endothelial Dysfunction","volume":"9","author":"Cho","year":"2018","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116787_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97470-6","article-title":"Right ventricular myocardial oxygen tension is reduced in monocrotaline-induced pulmonary hypertension in the rat and restored by myo-inositol trispyrophosphate","volume":"11","author":"Okni\u0144ska","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116787_bib64","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jacc.2016.10.047","article-title":"The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension","volume":"69","author":"Vonk Noordegraaf","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116787_bib65","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1183\/09031936.00046612","article-title":"Pathobiology of pulmonary arterial hypertension and right ventricular failure","volume":"40","author":"Voelkel","year":"2012","journal-title":"Eur. Respir. J."},{"issue":"31","key":"10.1016\/j.biopha.2024.116787_bib66","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.2174\/1381612822666160614082712","article-title":"Energetic Metabolic Roles in Pulmonary Arterial Hypertension and Right Ventricular Remodeling","volume":"22","author":"Zhang","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.biopha.2024.116787_bib67","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.acvd.2019.10.009","article-title":"Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertension","volume":"113","author":"Antigny","year":"2020","journal-title":"Arch. Cardiovasc Dis."},{"issue":"1","key":"10.1016\/j.biopha.2024.116787_bib68","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/cvr\/cvw014","article-title":"Modulators of right ventricular apoptosis and contractility in a rat model of pulmonary hypertension","volume":"110","author":"Zungu-Edmondson","year":"2016","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2024.116787_bib69","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.118.035326","article-title":"Right Ventricular Fibrosis","volume":"139","author":"Andersen","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.116787_bib70","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cjca.2015.01.023","article-title":"Right ventricular adaptation and failure in pulmonary arterial hypertension","volume":"31","author":"Ryan","year":"2015","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.biopha.2024.116787_bib71","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.healun.2021.02.018","article-title":"Right ventricular adaptation to pressure-overload: Differences between chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension","volume":"40","author":"Braams","year":"2021","journal-title":"J. Heart Lung Transpl."},{"issue":"1","key":"10.1016\/j.biopha.2024.116787_bib72","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCRESAHA.113.301129","article-title":"The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure","volume":"115","author":"Ryan","year":"2014","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2024.116787_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.719058","article-title":"Sex Differences, Estrogen Metabolism and Signaling in the Development of Pulmonary Arterial Hypertension","volume":"8","author":"Sun","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.biopha.2024.116787_bib74","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4103\/2045-8932.87314","article-title":"Survival in pulmonary arterial hypertension: A brief review of registry data","volume":"1","author":"Pauwaa","year":"2011","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.biopha.2024.116787_bib75","doi-asserted-by":"crossref","DOI":"10.1172\/JCI129433","article-title":"17\u03b2-Estradiol and estrogen receptor \u03b1 protect right ventricular function in pulmonary hypertension via BMPR2 and apelin","volume":"131","author":"Frump","year":"2021","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2024.116787_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124314","article-title":"The Role of Estrogen Receptors in Cardiovascular Disease","volume":"21","author":"Aryan","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116787_bib77","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1164\/rccm.201101-0078OC","article-title":"Estrogen rescues preexisting severe pulmonary hypertension in rats","volume":"184","author":"Umar","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.biopha.2024.116787_bib78","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1183\/09031936.00044112","article-title":"Oestradiol ameliorates monocrotaline pulmonary hypertension via NO, prostacyclin and endothelin-1 pathways","volume":"41","author":"Yuan","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2024.116787_bib79","doi-asserted-by":"crossref","first-page":"L7","DOI":"10.1152\/ajplung.00337.2013","article-title":"Progress in solving the sex hormone paradox in pulmonary hypertension","volume":"307","author":"Lahm","year":"2014","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116787_bib80","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1183\/13993003.01083-2015","article-title":"Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function","volume":"47","author":"Ventetuolo","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.biopha.2024.116787_bib81","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201509-1785OC","article-title":"Higher estradiol and lower dehydroepiandrosterone-sulfate levels are associated with pulmonary arterial hypertension in men","volume":"193","author":"Ventetuolo","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"4","key":"10.1016\/j.biopha.2024.116787_bib82","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.chest.2021.10.010","article-title":"Novel mechanisms targeted by drug trials in pulmonary arterial hypertension","volume":"161","author":"Condon","year":"2022","journal-title":"Chest"},{"issue":"13","key":"10.1016\/j.biopha.2024.116787_bib83","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1093\/cvr\/cvad129","article-title":"Sex-biased TGF\u03b2 signalling in pulmonary arterial hypertension","volume":"119","author":"Wits","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.biopha.2024.116787_bib84","doi-asserted-by":"crossref","first-page":"1801899","DOI":"10.1183\/13993003.01899-2018","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"53","author":"Morrell","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2024.116787_bib85","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.chest.2020.01.013","article-title":"Genetics and other omics in pediatric pulmonary arterial hypertension","volume":"157","author":"Welch","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.biopha.2024.116787_bib86","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04172-2020","article-title":"The pathophysiological role of novel pulmonary arterial hypertension gene SOX17","volume":"58","author":"Wu","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2024.116787_bib87","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1183\/16000617.0036-2016","article-title":"Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives","volume":"25","author":"Chelladurai","year":"2016","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.biopha.2024.116787_bib88","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/HYPERTENSIONAHA.121.18399","article-title":"Calcium Sensing Receptor Variants Increase Pulmonary Hypertension Susceptibility","volume":"79","author":"Liu","year":"2022","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.biopha.2024.116787_bib89","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3390\/ijms22031179","article-title":"Genetic Delivery and Gene Therapy in Pulmonary Hypertension","volume":"22","author":"Rai","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2024.116787_bib90","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2024.116787_bib91","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/HYPERTENSIONAHA.118.10934","article-title":"Involvement of Neuroinflammation in the Pathogenesis of Monocrotaline-Induced Pulmonary Hypertension","volume":"71","author":"Sharma","year":"2018","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.biopha.2024.116787_bib92","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12890-022-01932-0","article-title":"Altered gut microbiota and its association with inflammation in patients with chronic thromboembolic pulmonary hypertension: a single-center observational study in Japan","volume":"22","author":"Ikubo","year":"2022","journal-title":"BMC Pulm. Med"},{"issue":"3","key":"10.1016\/j.biopha.2024.116787_bib93","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00253-2019","article-title":"Pulmonary arterial hypertension-associated changes in gut pathology and microbiota","volume":"6","author":"Sharma","year":"2020","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.biopha.2024.116787_bib94","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1080\/21655979.2021.1952365","article-title":"Changes in the gut microbiome and metabolome in a rat model of pulmonary arterial hypertension","volume":"12","author":"Hong","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.biopha.2024.116787_bib95","article-title":"Role of gut microbiota in pulmonary arterial hypertension","volume":"12","author":"Wu","year":"2022","journal-title":"Front Cell Infect. Microbiol"},{"issue":"6","key":"10.1016\/j.biopha.2024.116787_bib96","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1164\/rccm.202203-0490OC","article-title":"Pulmonary arterial hypertension patients have a proinflammatory gut microbiome and altered circulating microbial metabolites","volume":"207","author":"Moutsoglou","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.116787_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12015","article-title":"Fecal matter transplant from Ace2 overexpressing mice counteracts chronic hypoxia-induced pulmonary hypertension","volume":"12","author":"Oliveira","year":"2022","journal-title":"Pulm. Circ."},{"issue":"22","key":"10.1016\/j.biopha.2024.116787_bib98","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022722","article-title":"Intermittent fasting enhances right ventricular function in preclinical pulmonary arterial hypertension","volume":"10","author":"Prisco","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2024.116787_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113810","article-title":"Gut microbiota: a new insight into lung diseases","volume":"155","author":"Ma","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.116787_bib100","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.120.316443","article-title":"Epigenetic metabolic reprogramming of right ventricular fibroblasts in pulmonary arterial hypertension: a pyruvate dehydrogenase kinase-dependent shift in mitochondrial metabolism promotes right ventricular fibrosis","volume":"126","author":"Tian","year":"2020","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2024.116787_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052410","article-title":"Signal Transduction during Metabolic and Inflammatory Reprogramming in Pulmonary Vascular Remodeling","volume":"23","author":"Gomes","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116787_bib102","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163932","article-title":"Proline and glucose metabolic reprogramming supports vascular endothelial and medial biomass in pulmonary arterial hypertension","volume":"8","author":"Wertheim","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2024.116787_bib103","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1038\/s41467-018-06376-x","article-title":"Alpha-enolase regulates the malignant phenotype of pulmonary artery smooth muscle cells via the AMPK-Akt pathway","volume":"9","author":"Dai","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116787_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2022.106976","article-title":"G6PD is a critical enabler of hypoxia-induced accumulation of macrophages and platelets in mice lungs and contributor to lung inflammation","volume":"144","author":"Hashimoto","year":"2022","journal-title":"Vasc. Pharm."},{"key":"10.1016\/j.biopha.2024.116787_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102797","article-title":"Metabolic reprogramming, oxidative stress, and pulmonary hypertension","volume":"64","author":"Pokharel","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2024.116787_bib106","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1164\/rccm.202109-2075OC","article-title":"Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary Hypertension","volume":"205","author":"Manz","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.biopha.2024.116787_bib107","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cjca.2014.10.023","article-title":"Adaptation and remodelling of the pulmonary circulation in pulmonary hypertension","volume":"31","author":"Vaillancourt","year":"2015","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.biopha.2024.116787_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1268646","article-title":"Role of histone lactylation interference RNA m(6)A modification and immune microenvironment homeostasis in pulmonary arterial hypertension.","volume":"11","author":"Zhao","year":"2023","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2024.116787_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1206406","article-title":"Advances in epigenetic modifications of autophagic process in pulmonary hypertension","volume":"14","author":"Mao","year":"2023","journal-title":"Front Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2024.116787_bib110","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1164\/rccm.201007-1106OC","article-title":"Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats","volume":"183","author":"Bogaard","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.biopha.2024.116787_bib111","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fphar.2018.00241","article-title":"Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension","volume":"9","author":"Wang","year":"2018","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.116787_bib112","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.freeradbiomed.2016.12.016","article-title":"Quercetin induces autophagy via FOXO1-dependent pathways and autophagy suppression enhances quercetin-induced apoptosis in PASMCs in hypoxia","volume":"103","author":"He","year":"2017","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.biopha.2024.116787_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.720873","article-title":"Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension","volume":"12","author":"Xue","year":"2021","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116787_bib114","doi-asserted-by":"crossref","first-page":"19","DOI":"10.31083\/j.fbl2701019","article-title":"Modification Tadalafil and Macitentan tablets to aerosol","volume":"27","author":"Zarogoulidis","year":"2022","journal-title":"Front Biosci. (Landmark Ed."},{"issue":"11","key":"10.1016\/j.biopha.2024.116787_bib115","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/13543784.2023.2274439","article-title":"Emerging pharmacotherapies for the treatment of pulmonary arterial hypertension","volume":"32","author":"Auth","year":"2023","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2024.116787_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-023-00486-7","article-title":"Pulmonary hypertension","volume":"10","author":"Mocumbi","year":"2024","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"2","key":"10.1016\/j.biopha.2024.116787_bib117","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pharmthera.2013.10.002","article-title":"Targeted therapies in pulmonary arterial hypertension","volume":"141","author":"Montani","year":"2014","journal-title":"Pharm. Ther."},{"issue":"9","key":"10.1016\/j.biopha.2024.116787_bib118","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S2213-2600(23)00259-X","article-title":"Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management","volume":"11","author":"Olsson","year":"2023","journal-title":"Lancet Respir. Med"},{"issue":"19","key":"10.1016\/j.biopha.2024.116787_bib119","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.3390\/cells12192394","article-title":"Pulmonary Hypertension in Interstitial Lung Disease: Updates in Disease, Diagnosis, and Therapeutics","volume":"12","author":"Haynes","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2024.116787_bib120","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01915-2018","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"53","author":"Kim","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2024.116787_bib121","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.cjca.2014.04.016","article-title":"Oral anticoagulation for pulmonary arterial hypertension: systematic review and meta-analysis","volume":"30","author":"Caldeira","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.biopha.2024.116787_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100738","article-title":"Anticoagulation in Pulmonary Arterial Hypertension: Do We Know the Answer","volume":"46","author":"Rawal","year":"2021","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.biopha.2024.116787_bib123","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004757","article-title":"Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension","volume":"11","author":"Khan","year":"2018","journal-title":"Circ. Cardiovasc Qual. Outcomes"},{"key":"10.1016\/j.biopha.2024.116787_bib124","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCULATIONAHA.113.004526","article-title":"Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)","volume":"129","author":"Olsson","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.116787_bib125","first-page":"CD012621","article-title":"Phosphodiesterase 5 inhibitors for pulmonary hypertension","volume":"1","author":"Barnes","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2024.116787_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195047","article-title":"Synergistic interaction between a PDE5 inhibitor (sildenafil) and a new adenosine A2A receptor agonist (LASSBio-1359) improves pulmonary hypertension in rats","volume":"13","author":"Alencar","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2024.116787_bib127","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/cvr\/cvt109","article-title":"The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension","volume":"99","author":"Fan","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2024.116787_bib128","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.clinthera.2011.06.008","article-title":"Tadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension","volume":"33","author":"Arif","year":"2011","journal-title":"Clin. Ther."},{"key":"10.1016\/j.biopha.2024.116787_bib129","first-page":"CD002994","article-title":"Prostacyclin for pulmonary hypertension","author":"Paramothayan","year":"2002","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2024.116787_bib130","first-page":"CD002994","article-title":"Prostacyclin for pulmonary hypertension in adults","volume":"2005","author":"Paramothayan","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2024.116787_bib131","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/17476348.2017.1317599","article-title":"The prostacyclin pathway in pulmonary arterial hypertension: a clinical review","volume":"11","author":"Del Pozo","year":"2017","journal-title":"Expert Rev. Respir. Med"},{"key":"10.1016\/j.biopha.2024.116787_bib132","first-page":"CD012785","article-title":"Prostacyclin for pulmonary arterial hypertension","volume":"5","author":"Barnes","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2024.116787_bib133","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0055-2016","article-title":"Epoprostenol and pulmonary arterial hypertension: 20\u2005years of clinical experience","volume":"26","author":"Sitbon","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.biopha.2024.116787_bib134","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1542\/peds.2013-2330","article-title":"Subcutaneous treprostinil for pulmonary hypertension in chronic lung disease of infancy","volume":"134","author":"Ferdman","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.biopha.2024.116787_bib135","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1165\/rcmb.2019-0122ED","article-title":"CA Dreamin': Carbonic Anhydrase Inhibitors, Macrophages, and Pulmonary Hypertension","volume":"61","author":"Shimoda","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.biopha.2024.116787_bib136","doi-asserted-by":"crossref","DOI":"10.1152\/ajpregu.00362.2020","article-title":"Carbonic anhydrase inhibition improves pulmonary artery reactivity and nitric oxide-mediated relaxation in sugen-hypoxia model of pulmonary hypertension","volume":"320","author":"Christou","year":"2021","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.biopha.2024.116787_bib137","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1165\/rcmb.2018-0232OC","article-title":"Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension","volume":"61","author":"Hudalla","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.biopha.2024.116787_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.662870","article-title":"Acetazolamide Improves Right Ventricular Function and Metabolic Gene Dysregulation in Experimental Pulmonary Arterial Hypertension","volume":"8","author":"Spyropoulos","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"126","key":"10.1016\/j.biopha.2024.116787_bib139","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1183\/09059180.00005412","article-title":"Challenges in the diagnosis and treatment of pulmonary arterial hypertension","volume":"21","author":"Vachi\u00e9ry","year":"2012","journal-title":"Eur. Respir. Rev."},{"issue":"22","key":"10.1016\/j.biopha.2024.116787_bib140","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Gali\u00e8","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.116787_bib141","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2047-783X-18-16","article-title":"The effects and mechanism of ginsenoside Rg1 on myocardial remodeling in an animal model of chronic thromboembolic pulmonary hypertension","volume":"18","author":"Li","year":"2013","journal-title":"Eur. J. Med Res"},{"key":"10.1016\/j.biopha.2024.116787_bib142","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.21037\/jtd.2016.05.71","article-title":"Ginsenoside Rg1 attenuates hypoxia and hypercapnia-induced vasoconstriction in isolated rat pulmonary arterial rings by reducing the expression of p38","volume":"8","author":"Zheng","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.biopha.2024.116787_bib143","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jgr.2015.09.005","article-title":"Total ginsenosides suppress monocrotaline-induced pulmonary hypertension in rats: involvement of nitric oxide and mitogen-activated protein kinase pathways","volume":"40","author":"Qin","year":"2016","journal-title":"J. Ginseng Res"},{"key":"10.1016\/j.biopha.2024.116787_bib144","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1039\/C8MD00341F","article-title":"Protective effects of astragaloside IV against hypoxic pulmonary hypertension","volume":"9","author":"Zhang","year":"2018","journal-title":"Medchemcomm"},{"key":"10.1016\/j.biopha.2024.116787_bib145","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3892\/ijmm.2020.4813","article-title":"Astragaloside IV blocks monocrotaline\u2011induced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling","volume":"47","author":"Jin","year":"2021","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.biopha.2024.116787_bib146","article-title":"Astragaloside IV attenuates hypoxia\u2011induced pulmonary vascular remodeling via the Notch signaling pathway","volume":"23","author":"Yao","year":"2021","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.biopha.2024.116787_bib147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-079X.2012.01014.x","article-title":"A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives","volume":"54","author":"Mauriz","year":"2013","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.biopha.2024.116787_bib148","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/jpi.12128","article-title":"Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review","volume":"56","author":"Garc\u00eda","year":"2014","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.biopha.2024.116787_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061125","article-title":"Melatonin Attenuates pulmonary hypertension in chronically hypoxic rats","volume":"18","author":"Hung","year":"2017","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116787_bib150","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/jpi.12184","article-title":"Melatonin attenuates hypoxic pulmonary hypertension by inhibiting the inflammation and the proliferation of pulmonary arterial smooth muscle cells","volume":"57","author":"Jin","year":"2014","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.biopha.2024.116787_bib151","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.omtn.2018.08.015","article-title":"Identifying Involvement of H19-miR-675-3p-IGF1R and H19-miR-200a-PDCD4 in Treating Pulmonary Hypertension with Melatonin","volume":"13","author":"Wang","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.biopha.2024.116787_bib152","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13020-022-00568-w","article-title":"Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension","volume":"17","author":"Yu","year":"2022","journal-title":"Chin. Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.116787_bib153","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01889-2018","article-title":"Risk stratification and medical therapy of pulmonary arterial hypertension","volume":"53","author":"Gali\u00e8","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2024.116787_bib154","doi-asserted-by":"crossref","first-page":"696","DOI":"10.5858\/arpa.2016-0035-RA","article-title":"The evolving classification of pulmonary hypertension","volume":"141","author":"Foshat","year":"2017","journal-title":"Arch. Pathol. Lab Med"},{"key":"10.1016\/j.biopha.2024.116787_bib155","doi-asserted-by":"crossref","DOI":"10.7326\/AITC202104200","article-title":"Pulmonary hypertension","volume":"174","author":"Poch","year":"2021","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.biopha.2024.116787_bib156","first-page":"73","article-title":"Pulmonary Hypertension","volume":"114","author":"Hoeper","year":"2017","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.biopha.2024.116787_bib157","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.chest.2016.01.007","article-title":"Persistent Challenges in Pediatric Pulmonary Hypertension","volume":"150","author":"Hopper","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.biopha.2024.116787_bib158","doi-asserted-by":"crossref","first-page":"13394","DOI":"10.1073\/pnas.1821401116","article-title":"PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension","volume":"116","author":"Cao","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2024.116787_bib159","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.201709-1835OC","article-title":"Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension","volume":"198","author":"Dai","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.biopha.2024.116787_bib160","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/978-1-60761-500-2_28","article-title":"PDGF receptor and its antagonists: role in treatment of PAH","volume":"661","author":"Grimminger","year":"2010","journal-title":"Adv. Exp. Med Biol."},{"key":"10.1016\/j.biopha.2024.116787_bib161","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1113\/JP275856","article-title":"Pulmonary vascular dysfunction in metabolic syndrome","volume":"597","author":"Willson","year":"2019","journal-title":"J. Physiol."},{"key":"10.1016\/j.biopha.2024.116787_bib162","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.amjcard.2012.03.042","article-title":"Serum high-density lipoprotein cholesterol levels as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension","volume":"110","author":"Zhao","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.biopha.2024.116787_bib163","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fphar.2016.00418","article-title":"Dihydrotanshinone I Attenuates Atherosclerosis in ApoE-deficient mice: role of NOX4\/NF-\u03baB Mediated Lectin-Like Oxidized LDL Receptor-1 (LOX-1) of the Endothelium","volume":"7","author":"Zhao","year":"2016","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.116787_bib164","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2353\/ajpath.2010.090832","article-title":"Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells","volume":"176","author":"Fijalkowska","year":"2010","journal-title":"Am. J. Pathol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224006711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224006711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T19:44:24Z","timestamp":1741031064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224006711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":164,"alternative-id":["S0753332224006711"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116787","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A peripheral system disease\u2014Pulmonary hypertension","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116787"}}